These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8915161)

  • 21. MPGN type I induced by granulocyte colony stimulating factor.
    Magen D; Mandel H; Berant M; Ben-Izhak O; Zelikovic I
    Pediatr Nephrol; 2002 May; 17(5):370-2. PubMed ID: 12042897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Granulocyte colony stimulating factor treatment for delayed recovery of ticlopidine-related neutropenia.
    Hung MJ; Wang CH; Cherng WJ
    Int J Clin Pract; 2002; 56(1):70-1. PubMed ID: 11831843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant granulocyte colony-stimulating factor in the management of toxic epidermal necrolysis.
    Goulden V; Goodfield MJ
    Br J Dermatol; 1996 Aug; 135(2):305-6. PubMed ID: 8881680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Recombinant granulocyte colony-stimulating factor as a new effective treatment of neutropenia].
    Fasth A; Carlson G; Ridell B
    Lakartidningen; 1992 Mar; 89(10):776-80. PubMed ID: 1371816
    [No Abstract]   [Full Text] [Related]  

  • 25. Severe neutropenia after renal transplantation and its reversal with granulocyte colony-stimulating factor.
    Birkeland SA; Elbirk A; Rohr N; Jørgensen KA
    Transplant Proc; 1994 Dec; 26(6):3098-9. PubMed ID: 7527945
    [No Abstract]   [Full Text] [Related]  

  • 26. Non-myeloablative transplantation for severe congenital neutropenia.
    Thachil J; Caswell M; Bolton-Maggs PH; Pizer B; Keenan R
    Pediatr Blood Cancer; 2008 Apr; 50(4):920-1. PubMed ID: 17635003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current status of granulocyte (neutrophil) transfusion therapy for infectious diseases.
    Hübel K; Dale DC; Engert A; Liles WC
    J Infect Dis; 2001 Jan; 183(2):321-328. PubMed ID: 11112098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severe congenital neutropenia: a case study.
    Parker LA
    Neonatal Netw; 1997 Dec; 16(8):17-21. PubMed ID: 9429449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytosolic proteins from neutrophilic granulocytes: a comparison between patients with severe chronic neutropenia and healthy donors.
    Kasper B; Thole HH; Patterson SD; Welte K
    Electrophoresis; 1997 Jan; 18(1):142-9. PubMed ID: 9059836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O; Foss B; Petersen H
    Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Granulocyte colony-stimulating factor: a new approach in the treatment of childhood neutropenia.
    Little FM; Pais RC; Winton E; Ragab AH
    J Med Assoc Ga; 1992 Aug; 81(8):437-41. PubMed ID: 1380973
    [No Abstract]   [Full Text] [Related]  

  • 32. Chemotherapy and granulocyte colony-stimulating factor in ovarian cancer.
    Ochiai K; Terashima Y
    Semin Oncol; 1994 Feb; 21(1 Suppl 1):23-8. PubMed ID: 7512275
    [No Abstract]   [Full Text] [Related]  

  • 33. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients.
    Root RK; Dale DC
    J Infect Dis; 1999 Mar; 179 Suppl 2():S342-52. PubMed ID: 10081506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Granulocyte colony stimulating factor in the management of chronic neutropenia.
    Marlton PV; Wright SJ; Taylor KM
    Med J Aust; 1992 May; 156(10):729-31. PubMed ID: 1377771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Granulocyte colony-stimulating factor in afebrile patients with neutropenia.
    Cabanillas F
    N Engl J Med; 1997 Oct; 337(18):1319-20. PubMed ID: 9380086
    [No Abstract]   [Full Text] [Related]  

  • 36. Severe neutropenia in an infant with methylmalonic acidemia.
    Guerra-Moreno J; Barrios N; Santiago-Borrero PJ
    Bol Asoc Med P R; 2003; 95(1):17-20. PubMed ID: 12898746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Severe chronic neutropenia: pathophysiology and therapy.
    Welte K; Boxer LA
    Semin Hematol; 1997 Oct; 34(4):267-78. PubMed ID: 9347577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of a new formulation of lenograstim (recombinant glycosylated human granulocyte colony-stimulating factor) containing gelatin for the treatment of neutropenia after consolidation chemotherapy in patients with acute myeloid leukemia.
    Takeshita A; Saito H; Toyama K; Horiuchi A; Kuriya S; Furusawa S; Tsuruoka N; Takiguchi T; Matsuda T; Utsumi M; Shiku H; Matsui T; Egami K; Tamura K; Ohno R
    Int J Hematol; 2000 Feb; 71(2):136-43. PubMed ID: 10745623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: a meta-analysis of randomized controlled trials.
    Sung L; Nathan PC; Lange B; Beyene J; Buchanan GR
    J Clin Oncol; 2004 Aug; 22(16):3350-6. PubMed ID: 15310780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful treatment of scleromyxoedema with high dose intravenous immunoglobulin.
    Karim A; Lawlor F; Black MM
    Clin Exp Dermatol; 2004 May; 29(3):317-8. PubMed ID: 15115524
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.